Back to Search Start Over

PATIENT INFORMATION SHEET: Risperidone (generic) Risperdal (brand).

Source :
Brown University Child & Adolescent Psychopharmacology Update. Sep2012 Supplement, Vol. 14, p1-2. 2p.
Publication Year :
2012

Abstract

The article offers information about the atypical antipsychotics risperidone. It notes that the drug has Food and Drug Administration (FDA)-approved indications for the treatment of schizophrenia and short-term treatment of acute mania or mixed episodes associated with bipolar disorder. Also offered are the potential risks and side effects of risperidone therapy as well as there interactions with drugs or foods.

Subjects

Subjects :
*HYPERGLYCEMIA
*CEREBROVASCULAR disease risk factors
*TARDIVE dyskinesia
*NEUROLEPTIC malignant syndrome
*AUTISM
*COMBINATION drug therapy
*DRUG interactions
*DRUG storage
*LITHIUM
*BIPOLAR disorder
*PHARMACY information services
*RISPERIDONE
*VALPROIC acid
*ADOLESCENCE
*CHILDREN
*DISEASE risk factors
DRUG therapy for schizophrenia

Details

Language :
English
ISSN :
15278395
Volume :
14
Database :
Academic Search Index
Journal :
Brown University Child & Adolescent Psychopharmacology Update
Publication Type :
Academic Journal
Accession number :
79445915

Tools

Authors Abstract Subjects Details